Need help with Investor Relations? Read our new eBook.Download Now

Westicke Partners IPO Advisory
Strategic Investor Relations
Independent Capital Markets Advice

Mobile Navigation

Robert Uhl, MBA

Robert Joined Westwicke Partners in 2011 as a member of the life science team where he works with both public and private companies in the specialty pharmaceutical and biotechnology sector. His expertise spans the spectrum of investor relations activities including strategic buy-side and sell-side relationship building, corporate messaging and positioning, and investor perception audits.

Biography

Robert Uhl

Robert has over 20 years of Wall Street experience on both the sell-side and buy-side, primarily as a financial analyst and as director of equity research. He also brings over three years of experience on the corporate side as an investor relations officer at a biotechnology company. Just prior to joining Westwicke, Robert served as Senior Director, Investor Relations with Halozyme Therapeutics. His responsibilities included oversight of all communications with the investment community including details of Halozyme’s business plan and development programs in oncology, immunology and diabetes. He also assisted in two successful capital raises for Halozyme, directed the media relations initiative, and updated and maintained the company website.

Prior to Halozyme, he served as vice president, specialty pharmaceuticals analyst with FBR Capital Markets in Arlington, Virginia. Mr. Uhl has spent most of his career as a healthcare financial analyst following the branded and generic pharmaceutical and biotechnology sectors and, as director of equity research. Prior to FBR, Robert was employed at Leerink, Swann & Co., Salomon Brothers, and Curran Capital Management. During his career, Robert has assisted numerous companies with initial public offerings and capital raises. Before entering the investment field, Mr. Uhl worked in equine pharmacology research at the University of Kentucky. Currently Robert serves on the board of the San Diego Chapter of the National Investor Relations Institute (NIRI).

Robert earned a BS in microbiology from Purdue University and an MBA in international business studies from the University of South Carolina. He lives in San Diego, California, with his family.

Read blog posts by Robert Uhl >>

Read Our Insider’s Guide to Investor Relations

Click here to download our new eBook, Westwicke Partners Insider’s Guide to Investor Relations, for our team’s insights on all things IR-related.

DOWNLOAD NOW

Our Locations